Abstract
Protein-protein interactions play a crucial role in numerous vital cell functions. However proteinprotein interactions are also responsible for pathological formation of protein aggregates, which determine the development of several diseases. The key role of protein-protein interactions for manifestation of numerous cell functions attracts much attention to protein complexes as perspective drug targets. So design or discovery of small molecules that would regulate protein-protein interactions represents great pharmacological interest. The recent progress in understanding of mechanism protein-protein interaction, including role of flexibility of protein-protein interfaces, thermodynamic of complex formation, discovery of small molecules modifying protein-protein interactions, the advantages and limitation of protein-protein inhibitors as potential drugs are discussed in this review.
Keywords: Protein-protein interaction, inhibitors, target, dimerization, drug, flexibility, allosteric inhibition
Current Computer-Aided Drug Design
Title: Inhibitors of Protein-Protein Interactions as Potential Drugs
Volume: 3 Issue: 1
Author(s): Alexander V. Veselovsky and Alexander I. Archakov
Affiliation:
Keywords: Protein-protein interaction, inhibitors, target, dimerization, drug, flexibility, allosteric inhibition
Abstract: Protein-protein interactions play a crucial role in numerous vital cell functions. However proteinprotein interactions are also responsible for pathological formation of protein aggregates, which determine the development of several diseases. The key role of protein-protein interactions for manifestation of numerous cell functions attracts much attention to protein complexes as perspective drug targets. So design or discovery of small molecules that would regulate protein-protein interactions represents great pharmacological interest. The recent progress in understanding of mechanism protein-protein interaction, including role of flexibility of protein-protein interfaces, thermodynamic of complex formation, discovery of small molecules modifying protein-protein interactions, the advantages and limitation of protein-protein inhibitors as potential drugs are discussed in this review.
Export Options
About this article
Cite this article as:
Veselovsky V. Alexander and Archakov I. Alexander, Inhibitors of Protein-Protein Interactions as Potential Drugs, Current Computer-Aided Drug Design 2007; 3 (1) . https://dx.doi.org/10.2174/157340907780058754
DOI https://dx.doi.org/10.2174/157340907780058754 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Roles of TRAF6 in Central Nervous System
Current Neuropharmacology Targeting Microglial Activation in Stroke Therapy: Pharmacological Tools and Gender Effects
Current Medicinal Chemistry Identification of Pharmacological Targets in Amyotrophic Lateral Sclerosis Through Genomic Analysis of Deregulated Genes and Pathways
Current Genomics Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Special Issue on Stem Cells: An Introduction from the Guest Editor
Current Neurovascular Research Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design
CNS & Neurological Disorders - Drug Targets Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
Current Alzheimer Research The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration
CNS & Neurological Disorders - Drug Targets Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients
Current Alzheimer Research Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Intracompartmental Delivery of CNTF as Therapy for Huntingtons Disease and Retinitis Pigmentosa
Current Gene Therapy Contrasting Roles of the Galectin-3 in the Schizophrenia Onset, Clinical Presentation, and Somatic Comorbidity
Current Topics in Medicinal Chemistry Aluminum Induced Immunoexcitotoxicity in Neurodevelopmental and Neurodegenerative Disorders
Current Inorganic Chemistry (Discontinued) Application of NMR Spectroscopy in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry Preface
Current Enzyme Inhibition Nanoparticle-Based Gene Therapy Intervention for Stroke Treatment: A Systematic Review
Current Gene Therapy Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders
Current Medicinal Chemistry